Recent Advances in the Development of P-gp Inhibitors

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 4, 2009-05 ,pp. : 415-436

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Aberrant TGF-&bgr; Signaling in Pre-Clinical Models of Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 7, Iss. 5, 2007-01 ,pp. : 504-514

Bentham Science Publishers

Access to resources Recommend Favorite

Dihydrodiol dehydrogenases regulate the generation of reactive oxygen species and the development of cisplatin resistance in human ovarian carcinoma cells

By Chen Jianli   Adikari Mahesha   Pallai Rajash   Parekh Hemant   Simpkins Henry  

Cancer Chemotherapy and Pharmacology, Vol. 61, Iss. 6, 2008-05 ,pp. : 979-987

Springer Publishing Company

Access to resources Recommend Favorite

Anti-Angiogenic Cancer Therapy Based on Integrin v&bgr;3 Antagonism

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 6, Iss. 5, 2006-09 ,pp. : 407-428

Bentham Science Publishers

Access to resources Recommend Favorite

Pre-clinical development of farnesyltransferase inhibitors

By Lobell R.B.   Kohl N.E.  

Cancer and Metastasis Reviews, Vol. 17, Iss. 2, 1998-06 ,pp. : 203-210

Springer Publishing Company

Access to resources Recommend Favorite